TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.
Hepatocellular Cancer
TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.
A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
-
Banner University Medical Center, Phoenix, Arizona, United States, 85006
University of Arkansas, Little Rock, Arkansas, United States, 72205
University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California, United States, 90033
Stanford University, Palo Alto, California, United States, 94304
California Liver Research Institute, Pasadena, California, United States, 91105
University of California-Davis, Sacramento, California, United States, 95817
University of California, San Francisco, California, United States, 94158
Georgetown University, Washington, District of Columbia, United States, 20007
Gastro Florida, Clearwater, Florida, United States, 33762
University of Florida Hepatology Research at CTRB, Gainesville, Florida, United States, 32610-0272
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Target PharmaSolutions, Inc.,
2024-10